2018
DOI: 10.1016/j.ijpharm.2018.02.022
|View full text |Cite
|
Sign up to set email alerts
|

A review of implantable biosensors for closed-loop glucose control and other drug delivery applications

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
71
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 74 publications
(71 citation statements)
references
References 177 publications
0
71
0
Order By: Relevance
“…To date, the biggest challenge of the implantable glucose sensors is how to improve the sensitivity while maintain good linearity, biocompatibility and lifetime [5,35]. There are several ways to solve this problem, including maximizing sensing surface of the electrode; reducing the negative effects of oxygen deficiency; balancing high sensitivity and wide linear detection range; increasing the signal to noise ratio; and, maintaining the stability of the sensor for a long time.…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…To date, the biggest challenge of the implantable glucose sensors is how to improve the sensitivity while maintain good linearity, biocompatibility and lifetime [5,35]. There are several ways to solve this problem, including maximizing sensing surface of the electrode; reducing the negative effects of oxygen deficiency; balancing high sensitivity and wide linear detection range; increasing the signal to noise ratio; and, maintaining the stability of the sensor for a long time.…”
Section: Discussionmentioning
confidence: 99%
“…Diabetes mellitus [1] is one of the pandemics characterized by chronic hyperglycemia [2], which seriously threatens human physical and mental health and quality of life. Since no cure has been developed for this disease, maintaining euglycemia through diet, exercise and pharmacological management is a way to prevent diabetic complications [3][4][5]. Currently, continuous glucose monitoring systems (CGMS) are increasingly popular, since they can reflect fluctuation of blood glucose (BG), easily perceive asymptomatic hypoglycemia and relieve the pain of sticking fingers frequently for people with diabetes [2,6,7].…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…Implantable biosensors have been developing to be used not only as a monitoring system of the biorhythms, [ 49 ] but also as a drug release system for the treatment of cancers or endocrine diseases including diabetes. [ 51 ] In the near future, these implantable devices are expected to be important tools for human electronic identification, internal body monitoring and also prevention or treatment of diseases. Nevertheless, after decades of market experience with animals, the intrabody mobility (i.e., migration) of the current injectable RFID tag is still a problem.…”
Section: Figurementioning
confidence: 99%